Urjas Delay Spray for men in just Rs. 69 X
Betabrim is a prescription medicine that is available as a Drops. Secondary and off-label uses of Betabrim have also been mentioned below.
The correct dosage of Betabrim depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Betabrim also has some side effects, the most common being Eye Burning, Eye irritation, Stinging in the Eyes. Apart from the aforementioned side effects, Betabrim can also lead to other problems, which have been listed below. Normally, these side effects of Betabrim are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Betabrim's effect is Mild during pregnancy and Unknown for lactating mothers. It is important to know if Betabrim has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Betabrim related warnings section.
Individuals suffering from medical conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Betabrim since this can cause severe adverse effects. Some other conditions that can be affected by Betabrim are listed in the contraindications section below.
Besides this, Betabrim may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Betabrim is safe while driving, and is addiction.
Betabrim is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Betabrim safe for pregnant women?
Betabrim has little to no side effects in pregnant women.
Is the use of Betabrim safe during breastfeeding?
There is no research available on the side effects of Betabrim in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Betabrim on the Kidneys?
Kidney can be affected by Betabrim. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Betabrim on the Liver?
Betabrim may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Betabrim on the Heart?
There may be an adverse effect on the heart after taking Betabrim. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Betabrim should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Betabrim unless your doctor advises you to do so -
Is this Betabrim habit forming or addictive?
No, you will not get addicted to Betabrim.
Interaction between Food and Betabrim
Taking Betabrim with food is safe.
Interaction between Alcohol and Betabrim
Information about the interaction of Betabrim and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)